drugset / Trial / NCT00481624
Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find a better, more convenient way to improve anemia results by increasing the amount of medication given at 3 week intervals. Researchers want to know if giving a higher dose of Procrit® and intravenous (IV) iron once every 3 weeks would give better results in treating anemia without the need for more office visits.
Timeline
- Start
- 2007-05
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 120000 iu | Subcutaneous |
| Background | ferric gluconate | Unknown | 125 mg | Intravenous |